221 related articles for article (PubMed ID: 9246798)
1. Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment.
Torrens M; San L; Martinez A; Castillo C; Domingo-Salvany A; Alonso J
Addiction; 1997 Jun; 92(6):707-16. PubMed ID: 9246798
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of mental and physical health disorders among older methadone patients.
Rosen D; Smith ML; Reynolds CF
Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
[TBL] [Abstract][Full Text] [Related]
3. [Subjective Quality of Life in opiate-dependent patients before admission after six months and one-year participation in methadone program].
Habrat B; Chmielewska K; Baran-Furga H; Keszycka B; Taracha E
Przegl Lek; 2002; 59(4-5):351-4. PubMed ID: 12184005
[TBL] [Abstract][Full Text] [Related]
4. Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial.
Robertson JR; Raab GM; Bruce M; McKenzie JS; Storkey HR; Salter A
Addiction; 2006 Dec; 101(12):1752-9. PubMed ID: 17156174
[TBL] [Abstract][Full Text] [Related]
5. One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients.
Soyka M; Apelt SM; Lieb M; Wittchen HU
J Clin Psychopharmacol; 2006 Dec; 26(6):657-60. PubMed ID: 17110826
[TBL] [Abstract][Full Text] [Related]
6. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification.
Masson CL; Barnett PG; Sees KL; Delucchi KL; Rosen A; Wong W; Hall SM
Addiction; 2004 Jun; 99(6):718-26. PubMed ID: 15139870
[TBL] [Abstract][Full Text] [Related]
7. Quality of life among heroin users on buprenorphine versus methadone maintenance.
Ponizovsky AM; Grinshpoon A
Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
[TBL] [Abstract][Full Text] [Related]
8. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
Maremmani I; Pani PP; Pacini M; Perugi G
J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494
[TBL] [Abstract][Full Text] [Related]
9. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
[TBL] [Abstract][Full Text] [Related]
10. Innovations in agonist maintenance treatment of opioid-dependent patients.
Haasen C; van den Brink W
Curr Opin Psychiatry; 2006 Nov; 19(6):631-6. PubMed ID: 17012944
[TBL] [Abstract][Full Text] [Related]
11. Controlled trial of prescribed heroin in the treatment of opioid addiction.
March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
[TBL] [Abstract][Full Text] [Related]
12. Analysis of behavioral patterns in five cohorts of patients retained in methadone maintenance programs.
Kott A; Habel E; Nottingham W
Mt Sinai J Med; 2001 Jan; 68(1):46-54. PubMed ID: 11135506
[TBL] [Abstract][Full Text] [Related]
13. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.
Karow A; Reimer J; Schäfer I; Krausz M; Haasen C; Verthein U
Drug Alcohol Depend; 2010 Dec; 112(3):209-15. PubMed ID: 20728288
[TBL] [Abstract][Full Text] [Related]
14. [Personality changes in opioid-dependent subjects in a methadone maintenance treatment program].
Trémeau F; Darreye A; Leroy B; Renckly V; Ertlé S; Weibel H; Khidichian F; Macher JP
Encephale; 2003; 29(4 Pt 1):285-92. PubMed ID: 14615698
[TBL] [Abstract][Full Text] [Related]
15. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.
King VL; Kidorf MS; Stoller KB; Schwartz R; Kolodner K; Brooner RK
J Subst Abuse Treat; 2006 Dec; 31(4):385-93. PubMed ID: 17084792
[TBL] [Abstract][Full Text] [Related]
16. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
Kastelic A; Dubajic G; Strbad E
Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
[TBL] [Abstract][Full Text] [Related]
17. [Comprehensive care of drug addiction during a 5-year period at the methadone center in Prague].
Popov P; Becka J; Wilczek H
Vnitr Lek; 2003 Nov; 49(11):851-8. PubMed ID: 14689681
[TBL] [Abstract][Full Text] [Related]
18. A 12-month evaluation of health-related quality of life outcomes of methadone maintenance program in a rural Malaysian sample.
Lua PL; Talib NS
Subst Use Misuse; 2012 Aug; 47(10):1100-5. PubMed ID: 22545914
[TBL] [Abstract][Full Text] [Related]
19. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
Ngo HT; Tait RJ; Hulse GK
Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
[TBL] [Abstract][Full Text] [Related]
20. Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence.
Strike CJ; Gnam W; Urbanoski K; Fischer B; Marsh DC; Millson M
Addict Behav; 2005 Jun; 30(5):1025-8. PubMed ID: 15893099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
